Congestive heart failure
Ischemic heart disease
Hypotension (Systolic blood pressure <100 mmHg)
Treatment with class I or III antiarrhythmic drugs
Severe hepatic or renal failure
Pregnancy or lactation
Hypersensitivity or contradictions to study drugs
Atrio-ventricular conduction disturbances
Thyrotoxicosis
Life limiting disease or substance abuse which may affect participation

NCT02695992_exc_T1
Condition
Congestive heart failure
NCT02695992_exc_T2
Condition
Ischemic heart disease
NCT02695992_exc_T3
Condition
Hypotension
NCT02695992_exc_T4
Measurement
Systolic blood pressure
NCT02695992_exc_T5
Value
<100 mmHg
NCT02695992_exc_T6
Scope
Systolic blood pressure <100 mmHg
NCT02695992_exc_T7
Qualifier
class I
NCT02695992_exc_T8
Qualifier
ss I  a
NCT02695992_exc_T9
Drug
antiarrhythmic drugs
NCT02695992_exc_T10
Scope
class I or III
NCT02695992_exc_T11
Qualifier
Severe
NCT02695992_exc_T12
Condition
renal failure
NCT02695992_exc_T13
Condition
tic or ure
Pre
NCT02695992_exc_T15
Scope
hepatic or renal failure
NCT02695992_exc_T16
Condition
Pregnancy
NCT02695992_exc_T17
Condition
lactation
NCT02695992_exc_T18
Condition
Hypersensitivity
NCT02695992_exc_T19
Condition
contradictions
NCT02695992_exc_T20
Drug
study drugs
NCT02695992_exc_T21
Scope
Hypersensitivity or contradictions
NCT02695992_exc_T23
Condition
Thyrotoxicosis
NCT02695992_exc_T24
Condition
Atrio-ventricular conduction disturbances
NCT02695992_exc_T25
Condition
Life limiting disease
NCT02695992_exc_T26
Condition
substance abuse
NCT02695992_exc_T27
Qualifier
may affect participation
NCT02695992_exc_T28
Scope
Life limiting disease or substance abuse